Private Market View

Galecto

Biotechnology

Last price · $/share
Implied valuation
Total raised
$285.0M
Last round
PIPE
Nov 2025

Key facts

  • It has raised $285.0M across 3 recorded rounds; the latest was PIPE ($285.0M) in Nov 2025.
  • 4 institutional filers report fund marks on Galecto across 12 filings.
  • Galecto has filed 3 Form Ds with the SEC since 2020, most recently Nov 2025 ($285.0M sold to 48 investors).
Free account
See the evidence behind this price
  • ·Post-money valuations for all 3 rounds
  • ·Watchlist + deal alerts for Galecto
Create free account
No card required

Funding rounds

3 rounds
Nov 2025PIPE$285.0M
Sep 2020Later Stage VC$64.2MSEC filing
Dec 2019Later Stage VC$79.1MSEC filing

About Galecto

Industry
Biotechnology
PA Mark — not yet priced

Galecto doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Galecto shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

4 filers · latest Feb 2026

4 SEC-registered funds reported 12 fair-value marks on Galecto between Nov 2025 and Feb 2026. Filer-level marks and implied $/share are available to Pro members.